Current knowledge on the clonal architecture of NPM1m AML shows that NPM1 mutation is often sub-clonal to DNMT3A, IDH1/2, or TET2 mutations, which can pre-exist as clonal hematopoiesis of indeterminate potential [12,13]. This evidence concerns the gene TET2 and acute myeloid leukemia.